NO145440C - Analogifremgangsmaate til fremstilling av et terapeutisk aktivt, nytt piperazinyluracilsalt - Google Patents

Analogifremgangsmaate til fremstilling av et terapeutisk aktivt, nytt piperazinyluracilsalt

Info

Publication number
NO145440C
NO145440C NO770411A NO770411A NO145440C NO 145440 C NO145440 C NO 145440C NO 770411 A NO770411 A NO 770411A NO 770411 A NO770411 A NO 770411A NO 145440 C NO145440 C NO 145440C
Authority
NO
Norway
Prior art keywords
piperazinyluracil
salt
preparing
new
therapeutic active
Prior art date
Application number
NO770411A
Other languages
English (en)
Norwegian (no)
Other versions
NO145440B (no
NO770411L (no
Inventor
Hermann Amschler
Kurt Klemm
Gerhard Ludwig
Wolfgang Schoetensack
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO770411L publication Critical patent/NO770411L/no
Publication of NO145440B publication Critical patent/NO145440B/no
Publication of NO145440C publication Critical patent/NO145440C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO770411A 1976-02-09 1977-02-08 Analogifremgangsmaate til fremstilling av et terapeutisk aktivt, nytt piperazinyluracilsalt NO145440C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU74319A LU74319A1 (el) 1976-02-09 1976-02-09

Publications (3)

Publication Number Publication Date
NO770411L NO770411L (no) 1977-08-10
NO145440B NO145440B (no) 1981-12-14
NO145440C true NO145440C (no) 1982-03-24

Family

ID=19728151

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770411A NO145440C (no) 1976-02-09 1977-02-08 Analogifremgangsmaate til fremstilling av et terapeutisk aktivt, nytt piperazinyluracilsalt

Country Status (20)

Country Link
US (1) US4131678A (el)
JP (2) JPS5296718A (el)
AT (1) AT347478B (el)
BE (1) BE851267A (el)
CA (1) CA1065865A (el)
CH (1) CH625792A5 (el)
DE (1) DE2704935C2 (el)
DK (1) DK52877A (el)
ES (1) ES455721A1 (el)
FI (1) FI61891C (el)
FR (1) FR2340316A1 (el)
GB (1) GB1512771A (el)
IE (1) IE44461B1 (el)
IL (1) IL51400A (el)
IT (1) IT1075919B (el)
LU (1) LU74319A1 (el)
NL (1) NL7701289A (el)
NO (1) NO145440C (el)
SE (1) SE7701441L (el)
YU (1) YU32477A (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58130183U (ja) * 1982-02-26 1983-09-02 株式会社ブレスト工業研究所 空調ダクト等の吊持装置
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
CN100353944C (zh) * 2004-06-24 2007-12-12 杨立新 乌拉地尔大容量注射液、其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
BE755015A (fr) * 1969-08-20 1971-02-01 Byk Gulden Lomberg Chem Fab Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation
JPS5212560A (en) * 1975-07-21 1977-01-31 Hitachi Ltd Electronic beam probe control device

Also Published As

Publication number Publication date
FR2340316A1 (fr) 1977-09-02
CH625792A5 (el) 1981-10-15
BE851267A (fr) 1977-08-09
FR2340316B1 (el) 1980-02-08
DE2704935A1 (de) 1977-08-11
IE44461L (en) 1977-08-09
FI61891C (fi) 1982-10-11
JPS5726618A (en) 1982-02-12
IL51400A (en) 1980-12-31
JPS5296718A (en) 1977-08-13
GB1512771A (en) 1978-06-01
FI61891B (fi) 1982-06-30
LU74319A1 (el) 1977-08-19
US4131678A (en) 1978-12-26
CA1065865A (en) 1979-11-06
ES455721A1 (es) 1978-01-01
AT347478B (de) 1978-12-27
NL7701289A (nl) 1977-08-11
IT1075919B (it) 1985-04-22
YU32477A (en) 1982-06-30
JPS5713544B2 (el) 1982-03-17
DE2704935C2 (de) 1985-01-10
IE44461B1 (en) 1981-12-02
NO145440B (no) 1981-12-14
NO770411L (no) 1977-08-10
FI770406A (el) 1977-08-10
IL51400A0 (en) 1977-04-29
ATA81777A (de) 1978-05-15
SE7701441L (sv) 1977-08-10
DK52877A (da) 1977-08-10

Similar Documents

Publication Publication Date Title
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
SE7704689L (sv) Forfarande for framstellning av insulin
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE428685B (sv) Analogiforfarande for framstellning av cyanosubstituerade (3-lagalkylamino-2-acyl-0-propoxi)pyridiner
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
NO145440C (no) Analogifremgangsmaate til fremstilling av et terapeutisk aktivt, nytt piperazinyluracilsalt
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE435381B (sv) Forfarande for framstellning av hypotensiva 2-(4-furoylpiperazin-1-yl)-4-amino-6,7-dimetoxikinazolin
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
NO150965C (no) Fremgangsmaate for fremstilling av en xantanopploesning
NO149471C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
NO147108C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-amino-lavere-alkyl-3,4-difenyl-1h-pyrazoler
NO146600C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater
NO145790C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt, nytt pyrimidin-derivat